Apotex Corp. recalls Desmopressin Nasal Spray
- Published
- 22 Apr 2026
- Units affected
- N/A
- Agency
- FDA
- Country
- United States
The hazard
Defective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Desmopressin Nasal Spray, USP, 10 mcg/0.1 mL, 5 mL bottle (50 doses), Rx only, Mfg by: Apotek inc., Toronto, Ontario, Canada, M9L 1T9, Mfg for: Apotek Corp., Weston, FL 33326, NDC 60505-0815-0
- Brand / company
- Apotex Corp.
- Codes / lots
- Lot #: VM4231, Exp 06/30/2027
- Distribution
- U.S.A. Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 22 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.